Q4 2024 marked the conclusion of a turnaround year for life sciences venture investment. After two consecutive years of declining activity and macroeconomic uncertainty, the dust has settled, and investment is back on the...more
Since the previous quarter’s Life Sciences Snapshot, robust dealmaking activity in Q3 has launched YTD life sciences VC deal activity to near parity with 2023 figures, firmly positioning 2024 as the year to break the two-year...more
Consumer brands are emerging to serve unmet needs in everything from health and wellness to sustainability. Josh Beser and Samir Bakhru were fortunate to meet many of these new companies and investors at the Consensus Great...more